Castle Biosciences CSTL Finance Lease Liabilities (Total)
Finance Lease Liabilities (Total) at other companies
Other financials
Where this comes from
Reported directly by Castle Biosciences in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseLiability.
The official record: Castle Biosciences’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Castle Biosciences's finance lease liabilities (total).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Castle Biosciences's finance lease liabilities (total)?
- Castle Biosciences (CSTL) reported finance lease liabilities (total) of $416K in Q4 2025.
- How has Castle Biosciences's finance lease liabilities (total) changed year-over-year?
- Castle Biosciences's finance lease liabilities (total) increased by 1.0% year-over-year, from $412K to $416K.
- What is the long-term trend for Castle Biosciences's finance lease liabilities (total)?
- Over 4 years (2021 to 2025), Castle Biosciences's finance lease liabilities (total) has grown at a 16.1% compound annual growth rate (CAGR), from $229K to $416K.
- What does finance lease liabilities (total) mean?
- Finance lease liabilities (total) represent the aggregate present value of all future lease payments for assets where the company assumes substantially all risks and rewards of ownership. This metric reflects the long-term debt-like burden associated with financing infrastructure or equipment through leases. It is a key component of the company's total leverage profile.